Decoding the activated stem cell phenotype of the neonatally maturing pituitary.

WNT signaling developmental biology mouse organoids pituitary regenerative medicine single-cell RNA-sequencing stem cells tissue maturation

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
14 06 2022
Historique:
received: 22 11 2021
accepted: 13 06 2022
pubmed: 15 6 2022
medline: 30 7 2022
entrez: 14 6 2022
Statut: epublish

Résumé

The pituitary represents the endocrine master regulator. In mouse, the gland undergoes active maturation immediately after birth. Here, we in detail portrayed the stem cell compartment of neonatal pituitary. Single-cell RNA-sequencing pictured an active gland, revealing proliferative stem as well as hormonal (progenitor) cell populations. The stem cell pool displayed a hybrid epithelial/mesenchymal phenotype, characteristic of development-involved tissue stem cells. Organoid culturing recapitulated the stem cells' phenotype, interestingly also reproducing their paracrine activity. The pituitary stem cell-activating interleukin-6 advanced organoid growth, although the neonatal stem cell compartment was not visibly affected in The pituitary gland is a pea-sized structure found just below the brain that produces hormones controlling everything from growth and stress to reproduction and immunity. To perform its role, the pituitary gland needs specialised hormone-producing cells, but it also contains stem cells. These stem cells can divide to produce more cells like themselves, or differentiate into cells of different types, including hormone-producing cells. In mice, the stem cells of the pituitary gland appear to be activated in the first few weeks after birth, and later become ‘quiescent’ (or lazy) in the adult pituitary gland. However, it remains unclear how the activated state found in the maturing gland is established and regulated. To answer this question, Laporte et al. used single-cell RNA sequencing, a technique that allows researchers to profile which genes are active in individual cells, which can provide vital information about the state and activity of a tissue. The researchers compared the cells of the maturing pituitary gland of newborn mice to the cells in the established gland of adult mice. This analysis revealed that the maturing pituitary gland is a dynamic tissue, with populations of cells that are actively dividing (including the stem cells), which the mature pituitary gland lacks. Additionally, Laporte et al. established the molecular basis for the activated state of the stem cells in the maturing pituitary gland, which relies on the activation of a cell signalling pathway called WNT. To confirm these findings, Laporte et al. used an organoid system that allowed them to recapitulate the stem cell compartment of the maturing pituitary gland in a dish. When Laporte et al. blocked WNT signalling in these organoids, the organoids failed to form or divide. Furthermore, blocking the pathway directly in newborn mice reduced the number of dividing stem cells in the pituitary gland. Both findings support the notion that WNT signalling is required to establish the activated state of the maturing pituitary gland in newborn mice. Laporte et al. also wanted to know whether the newborn pituitary gland responded to injury differently than the adult gland. It had already been established that the adult pituitary stem cells become activated upon injury, and that the gland has some regenerative capacity. However, when Laporte et al. injured the newborn pituitary gland, the gland was able to fully regenerate, despite the stem cells not becoming more activated. This is likely because these cells are already activated (or ‘primed’), and do not require further activation to divide and repair the gland with the help of other proliferating cells. With these results, Laporte et al. shed light on the activated state of the stem cells in the pituitary gland of newborn mice. This provides insight into the role of these stem cells, as well as unveiling possible routes towards regenerating pituitary tissue. This could eventually prove useful in medicine, in cases when the pituitary gland is damaged or removed.

Autres résumés

Type: plain-language-summary (eng)
The pituitary gland is a pea-sized structure found just below the brain that produces hormones controlling everything from growth and stress to reproduction and immunity. To perform its role, the pituitary gland needs specialised hormone-producing cells, but it also contains stem cells. These stem cells can divide to produce more cells like themselves, or differentiate into cells of different types, including hormone-producing cells. In mice, the stem cells of the pituitary gland appear to be activated in the first few weeks after birth, and later become ‘quiescent’ (or lazy) in the adult pituitary gland. However, it remains unclear how the activated state found in the maturing gland is established and regulated. To answer this question, Laporte et al. used single-cell RNA sequencing, a technique that allows researchers to profile which genes are active in individual cells, which can provide vital information about the state and activity of a tissue. The researchers compared the cells of the maturing pituitary gland of newborn mice to the cells in the established gland of adult mice. This analysis revealed that the maturing pituitary gland is a dynamic tissue, with populations of cells that are actively dividing (including the stem cells), which the mature pituitary gland lacks. Additionally, Laporte et al. established the molecular basis for the activated state of the stem cells in the maturing pituitary gland, which relies on the activation of a cell signalling pathway called WNT. To confirm these findings, Laporte et al. used an organoid system that allowed them to recapitulate the stem cell compartment of the maturing pituitary gland in a dish. When Laporte et al. blocked WNT signalling in these organoids, the organoids failed to form or divide. Furthermore, blocking the pathway directly in newborn mice reduced the number of dividing stem cells in the pituitary gland. Both findings support the notion that WNT signalling is required to establish the activated state of the maturing pituitary gland in newborn mice. Laporte et al. also wanted to know whether the newborn pituitary gland responded to injury differently than the adult gland. It had already been established that the adult pituitary stem cells become activated upon injury, and that the gland has some regenerative capacity. However, when Laporte et al. injured the newborn pituitary gland, the gland was able to fully regenerate, despite the stem cells not becoming more activated. This is likely because these cells are already activated (or ‘primed’), and do not require further activation to divide and repair the gland with the help of other proliferating cells. With these results, Laporte et al. shed light on the activated state of the stem cells in the pituitary gland of newborn mice. This provides insight into the role of these stem cells, as well as unveiling possible routes towards regenerating pituitary tissue. This could eventually prove useful in medicine, in cases when the pituitary gland is damaged or removed.

Identifiants

pubmed: 35699412
doi: 10.7554/eLife.75742
pii: 75742
pmc: PMC9333987
doi:
pii:

Banques de données

GEO
['GSE142653']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022, Laporte et al.

Déclaration de conflit d'intérêts

EL, FH, SD, AV, DL, CN, BC, HV No competing interests declared

Références

Elife. 2016 Jun 28;5:
pubmed: 27351100
Elife. 2021 Jan 05;10:
pubmed: 33399538
J Endocrinol. 1988 Apr;117(1):5-10
pubmed: 3356958
Nat Commun. 2019 Aug 23;10(1):3807
pubmed: 31444346
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25):
pubmed: 34161279
Eur J Endocrinol. 2005 Jul;153(1):1-12
pubmed: 15994739
Genesis. 2007 Sep;45(9):593-605
pubmed: 17868096
Genome Biol. 2018 Mar 14;19(1):31
pubmed: 29540203
Endocrinology. 1982 Feb;110(2):513-23
pubmed: 6799274
Mol Cell Endocrinol. 2014 Mar 25;385(1-2):2-17
pubmed: 23994027
eNeuro. 2020 Jan 17;7(1):
pubmed: 31915267
Endocrinology. 1978 Sep;103(3):724-35
pubmed: 84753
J Clin Med. 2016 Apr 06;5(4):
pubmed: 27058562
Dev Neurosci. 2004 Mar-Aug;26(2-4):148-65
pubmed: 15711057
Genes Dev. 2006 Oct 1;20(19):2739-53
pubmed: 17015435
Stem Cells Dev. 2012 Mar 20;21(5):801-13
pubmed: 21970375
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Nat Methods. 2015 Jun;12(6):481-3
pubmed: 26020499
Nature. 1994 Mar 24;368(6469):339-42
pubmed: 8127368
J Endocrinol. 2019 Feb 1;240(2):287-308
pubmed: 30475227
Endocrinology. 2016 Feb;157(2):705-21
pubmed: 26653762
Endocrinology. 2012 Jul;153(7):3224-35
pubmed: 22518061
Nat Protoc. 2019 Jun;14(6):1756-1771
pubmed: 31053799
Bioinformatics. 2018 Apr 1;34(7):1208-1214
pubmed: 29186351
J Vis Exp. 2022 Feb 25;(180):
pubmed: 35285833
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Development. 2014 Feb;141(4):816-29
pubmed: 24496619
Nat Methods. 2017 Nov;14(11):1083-1086
pubmed: 28991892
Circulation. 2018 Jul 24;138(4):412-423
pubmed: 30571359
Endocrinology. 2018 Dec 1;159(12):3910-3924
pubmed: 30335147
Prog Mol Biol Transl Sci. 2016;143:1-48
pubmed: 27697200
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Stem Cell Reports. 2015 Dec 8;5(6):1196-1209
pubmed: 26651607
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
J Endocrinol. 2017 Sep;234(3):R135-R158
pubmed: 28615294
Cell Tissue Res. 1990 Aug;261(2):333-8
pubmed: 2401005
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Stem Cells. 2009 May;27(5):1182-95
pubmed: 19418455
Nat Commun. 2020 Oct 19;11(1):5275
pubmed: 33077725
Regen Med. 2014;9(4):513-34
pubmed: 25159067
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2907-12
pubmed: 18287078
BMC Genomics. 2013 Aug 20;14:568
pubmed: 23961710
Cell Stem Cell. 2013 Oct 3;13(4):419-32
pubmed: 24094323
Cell Stem Cell. 2013 Oct 3;13(4):433-45
pubmed: 24094324
Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):
pubmed: 28620096
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204
Anat Embryol (Berl). 2002 Dec;206(1-2):1-11
pubmed: 12478362
Protein Cell. 2020 Aug;11(8):565-583
pubmed: 32193873
Front Endocrinol (Lausanne). 2021 Jan 29;11:604519
pubmed: 33584539
Bioinformatics. 2019 Jun 1;35(12):2159-2161
pubmed: 30445495

Auteurs

Emma Laporte (E)

Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Florian Hermans (F)

Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Laboratory of Morphology, Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.

Silke De Vriendt (S)

Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Annelies Vennekens (A)

Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Diether Lambrechts (D)

Center for Cancer Biology, VIB, Leuven, Belgium.
Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.

Charlotte Nys (C)

Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Benoit Cox (B)

Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Hugo Vankelecom (H)

Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH